Dr Matthew Griffin

Title: Consultant Clinical Oncologist


MBChB (Hons), MRCP (UK), MSc, Oncology FRCR


Radiotherapy, Chemotherapy, Hormonal Therapy, Biological Therapy

Current NHS Post

Nottingham City Hospital

Year Qualified


Clinical Interests

Breast Cancer, Head & Neck Cancer, Neuro-oncology

Research Interests

Ovarian Cancer, Breast Cancer

Professional Memberships
  • Fellow of the Royal College of Radiologists

Dr Griffin specialises in using radiotherapy and chemotherapy to treat breast cancer, brain tumours, and head and neck cancers.  He uses intensity modulated radiotherapy (IMRT) with image guidance (IGRT) routinely in his clinical practice for the treatment of complex head and neck and brain tumours and has recently also started using IMRT for all breast cancers.  In his NHS post in Nottingham he is chair of the specialty clinical governance group and is departmental audit lead for oncology, facilitating participation in local and national audit projects to ensure they deliver best clinical practice.

Latest News

  • October 3, 2015
    Early Docetaxel for prostate cancer improves survival

    Early treatment with Docetaxel chemotherapy imp...

    Read More
  • July 30, 2015
    Prostate Cancer Genetic Signatures

    A better understanding of the genetics of prost...

    Read More
  • May 13, 2015
    Where are the voices for radiotherapy?

    It is not well publicised – but the main ...

    Read More